Publication

Byline

Nancy Guthrie's kidnappers 'terrified', claims expert as search enters 3rd month

India, March 30 -- As the search to locate Nancy Guthrie enters its third month, a former FBI agent has claimed that the abductors of the 84-year-old missing woman will be "terrified" following her da... और पढ़ें


Performance Indicators for public officials to be prepared within 45 days

Nepal, March 30 -- The government has directed all public offices to prepare objective performance indicators along with Terms of References (ToR) within one and half month. Arguing that the underper... और पढ़ें


COPYRIGHT ROYALTY BOARD ISSUES RULE: ADJUSTMENT TO SOUND RECORDINGS BY NEW SUBSCRIPTION SERVICES AND EPHEMERAL RECORDINGS TO FACILITATE THOSE PERFORMANCES LICENSE 2026 ROYALTY RATES

WASHINGTON, March 30 -- Copyright Royalty Board has issued a rule called: Adjustment to Sound Recordings by New Subscription Services and Ephemeral Recordings To Facilitate Those Performances License ... और पढ़ें


Fitch flags rising risks in India's gold-loan segment amid price drop

New Delhi, March 30 -- A recent report by Fitch Ratings has flagged heightened risks in India's gold-loan segment following a decline in gold prices, underscoring the need for robust risk controls amo... और पढ़ें


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, March 30 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... और पढ़ें


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, March 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... और पढ़ें


Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, March 30 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... और पढ़ें


Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, March 30 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... और पढ़ें


Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, March 30 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and... और पढ़ें


Singapore Clinical Trial: A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asciminib in pediatric participants newly diagnosed or previously treated with Philadelphia positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) with or without known T315I mutation.

Singapore, March 30 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asci... और पढ़ें